Myeloperoxidase is required for neutrophil extracellular trap formation: implications for innate immunity

Kathleen D Metzler1, Tobias A Fuchs, William M Nauseef

  • 1Department of Cellular Microbiology, Max Planck Institute for Infection Biology, Berlin, Germany.

Blood
|October 27, 2010
PubMed

Insights

Myeloperoxidase (MPO) is essential for neutrophil extracellular trap (NET) formation. Complete MPO deficiency prevents NETs, impacting Candida albicans defense, while partial deficiency allows NETs, suggesting MPO

Area of Science:

  • Immunology
  • Cell Biology
  • Microbiology

Background:

  • Myeloperoxidase (MPO) is a key enzyme in neutrophil antimicrobial functions.
  • MPO deficiency in patients presents variable immunodeficiency severity.
  • Some MPO-deficient individuals experience severe infections, particularly with Candida species.

Purpose of the Study:

  • To investigate the role of MPO in neutrophil extracellular trap (NET) formation.
  • To determine if MPO is required for NET-dependent antimicrobial activity against Candida albicans.

Main Methods:

  • Analysis of NET formation in neutrophils from MPO-deficient and partially deficient donors.
  • Pharmacological inhibition of MPO to assess its effect on NET formation.
  • Evaluation of NET-dependent Candida albicans growth inhibition by MPO-deficient neutrophils.

Main Results:

  • Neutrophils completely deficient in MPO failed to form NETs.
  • Partially MPO-deficient neutrophils formed NETs, and MPO inhibition only delayed/reduced NET formation.
  • MPO-deficient neutrophils showed compromised inhibition of Candida albicans growth.

Conclusions:

  • MPO is required for neutrophil extracellular trap (NET) formation.
  • The inability to form NETs due to complete MPO deficiency may contribute to host defense defects.
  • MPO acts cell-autonomously in NET formation.